Gelonghui, April 17, 丨 China Biopharmaceutical (01177.HK) issued an announcement. On April 17, 2024, the trustee purchased an additional 5 million shares from the market and held them in trust on behalf of the selected participants in accordance with the terms and conditions of the program rules.
中国生物制药(01177.HK)：受托人根据限制性股份奖励计划购买500万股
China Biopharmaceutical (01177.HK): Trustee buys 5 million shares under restricted share award scheme
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.